The Effect of Aerobic Exercise on Lower Urinary System Symptoms in Women With Diabetes Mellitus
The Effect Of Aerobic Exercise On Bladder Function And Lower Urinary Tract Symptoms In Women Who Has Diabetes Mellitus With Lower Urinary Tract Symptoms
1 other identifier
interventional
44
1 country
1
Brief Summary
The goal of this clinical trial is to investigate the effect of aerobic exercise (AE) on bladder functions and urinary system symptoms in women diagnosed with Diabetes Mellitus (DM) and suffered from Lower Urinary Tract Symptoms (LUTS). In the study, 44 individuals (35-55 age) were divided into two groups: Aerobic Exercise (AE) (n=22) and Control Group (n=22) by simple random method. The main questions it aims to answer are:
- Is aerobic exercise effective on bladder functions in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms?
- Is aerobic exercise effective on urinary tract symptoms in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms?
- Is aerobic exercise effective on quality of life in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms? Intervention/treatment
- Control group individuals will be given a behavioral treatment program.
- Submaximal aerobic exercise training will be given to the AE group in addition to the behavioral treatment program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 3, 2023
CompletedFirst Submitted
Initial submission to the registry
January 12, 2024
CompletedFirst Posted
Study publicly available on registry
February 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedMarch 5, 2024
March 1, 2024
10 months
January 12, 2024
March 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Bladder Compliance
Bladder compliance will be evaluated by urodynamics. With urodynamic evaluations, pathologies of the lower urinary system can be diagnosed and classified. Urodynamic examinations are performed in a suitable laboratory environment. First of all, a suitable sterile catheter is placed in the bladder and isotonic fluid is filled into it at a certain speed. In this way, the behavior of the bladder and its muscles during urine filling, pressure measurements and behavior during urination are examined. Bladder functions are evaluated with urodynamic evaluations. With the urodynamic evaluation will be performed by the clinician in the urology outpatient clinic compliance (ml/cmH2O) will be recorded.
10 minutes (Change from Baseline at 12 weeks)
Bladder Sensation
Bladder sensation will be evaluated by urodynamics. With urodynamic evaluations, pathologies of the lower urinary system can be diagnosed and classified. Urodynamic examinations are performed in a suitable laboratory environment. First of all, a suitable sterile catheter is placed in the bladder and isotonic fluid is filled into it at a certain speed. In this way, the behavior of the bladder and its muscles during urine filling, pressure measurements and behavior during urination are examined. Bladder functions are evaluated with urodynamic evaluations. With the urodynamic evaluation will be performed by the clinician in the urology outpatient clinic sensation (ml) will be recorded.
10 minutes (Change from Baseline at 12 weeks)
Secondary Outcomes (11)
Voiding Volume
10 minutes (Change from Baseline at 12 weeks)
Voiding Time
10 minutes (Change from Baseline at 12 weeks)
Maximum Bladder Capacity
10 minutes (Change from Baseline at 12 weeks)
Urine Maximum Flow Rate
10 minutes (Change from Baseline at 12 weeks)
Bladder Residual Volume
10 minutes (Change from Baseline at 12 weeks)
- +6 more secondary outcomes
Study Arms (2)
Aerobic Exercise Group
EXPERIMENTALA behavioral treatment program will be applied to the patients. In addition, patients will be given submaximal aerobic exercise.
Control group
ACTIVE COMPARATORA behavioral treatment program will be applied to the patients.
Interventions
Aerobic Exercise training will be provided three days a week, 45 minutes a day, for 12 weeks. Patients will be subjected to submaximal aerobic exercise with rhythmic movements without equipment via video conference accompanied by a physiotherapist.
Behavioral Treatment Program will be completed with an initial training period of 40 minutes, and subsequent control interviews of 20 minutes at four-week intervals.
Eligibility Criteria
You may qualify if:
- Women between the ages of 35-55,
- Individuals who volunteer to participate in the study,
- Those diagnosed with Type II diabetes for 5 years or more and those diagnosed with LUTS
You may not qualify if:
- Stage 2 and more advanced pelvic organ prolapse,
- Urinary tract infection,
- Has had previous surgery for urinary incontinence and pelvic organ prolapse,
- Diagnosis of Cerebro Vascular Event (CVE) and dementia,
- Using A-blockers, antimuscarinics, antidepressants, diuretics and antihistamines,
- Individuals in menopause.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gaziantep Islam Science and Technology Universitylead
- University of Gaziantepcollaborator
- Hasan Kalyoncu Universitycollaborator
Study Sites (1)
Hasan Kalyoncu University
Gaziantep, 27000, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bengisu TÜFEKÇİ
Hasan Kalyoncu University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 12, 2024
First Posted
February 8, 2024
Study Start
May 3, 2023
Primary Completion
March 1, 2024
Study Completion
March 1, 2024
Last Updated
March 5, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share